Table 2. Prolactin levels (ng/mL) according to the etiology of the hyperprolactinemia in the Brazilian Multicenter Study on Hyperprolactinemia.
Etiology | N (%) | Mean PRL (range) (ng/mL) |
---|---|---|
Macroprolactinomas | 250 (20.2) | 1422.9 ± 3134.7 (108-21,200) |
Microprolactinomas | 444 (36) | 165.6 ± 255.1 (32-525) |
Idiopathic | 45 (3.6) | 163.9 ± 81.8 (46-328) |
Macroprolactinemia | 115 (9.3) | 119.5 ± 112.9 (32.5-404) |
Drug-induced | 180 (14.6) | 105.1 ± 73.2 (28-380) |
Acromegaly | 40 (3.2) | 99.3 ± 57.4 (28-275) |
NFPA | 82 (6.6) | 80.9 ± 54.5 (28-490) |
Primary hypothyroidism | 78 (6.3) | 74.6 ± 42.4 (30-253) |
NFPA: Non-functioning pituitary adenomas. Adapted from Ref. 34.